Skip to content

The Utility of Osteopathic Manipulative Medicine in Weaning Patients from the Ventilator Pilot Trial

The Utility of Osteopathic Manipulative Medicine in Weaning Patients from the Ventilator

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06891248
Enrollment
20
Registered
2025-03-24
Start date
2025-03-17
Completion date
2025-06-08
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteopathy in Diseases Classified Elsewhere, Respiratory Failure

Brief summary

The objectives of this research are to determine the treatment effect size of OMM to wean patients off of the ventilator, determine the number of patients needed for a larger study (power), determine the willingness of patients/POAs to be recruited, identify the correct dosing of OMM and whether there are concerns for the safety of treatment, and determine whether the hypothesis is feasible for a larger study. The primary outcome measure is the duration of time until a subject is weaned off of mechanical ventilation using Osteopathic Manipulative Medicine (OMM). The secondary outcome measures (see the next section for further explanation) are to determine if OMM affects changes in morbidity and mortality, such as VBG/ABG, NIF, RSBI, P 0.1, FiO2, PEEP, mental status, hemodynamic stability (blood pressure), spontaneous TV, reintubation after extubation, and death.

Interventions

PROCEDUREOsteopathic Manipulative Treatment

See treatment arm

Sponsors

Oklahoma State University Center for Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Acute respiratory failure (hypoxic, hypercapnic, or neuromuscular) 2. Not making satisfactory progress with weaning after being on the ventilator for more than 48 hours 3. Clinical stability for pressure support trial with ventilator to monitor ventilation progression 4. Pulmonology must be following the patient for standardized ventilator management approach and interventions as needed 5. Medical power of attorney (POA) or legally authorized representative (LAR) who is able to consent subject for trial enrollment and treatment 6. Patients who were not referred to the OMM service

Exclusion criteria

1. Age less than 18 years old or more than 85 years old 2. BMI\>60 3. Moderate/severe neurological disease with expectation of non-progression off the ventilator or poor quality of life predicted (including end-stage dementia with the expectation of non-progression off ventilator, multiple sclerosis, ALS, anoxic brain injury, etc) 4. Status epilepticus or EEG result pending 5. Post-arrest hypothermia protocol 6. Acute stroke 7. Acute rib fractures preventing the implementation of the treatment protocol 8. Acute spinal injury preventing the implementation of the treatment protocol 9. Recent head injury requiring close clinical monitoring 10. Ejection Fraction less than 15% 11. Pleural effusion requiring procedural intervention or inhibiting ventilator progress 12. Pericardial effusion or tamponade requiring procedural intervention or inhibiting ventilator progress 13. ACLS/cardiac arrest within the past 72 hours 14. Confirmed opioid overdose with positive urine drug screen and response to naloxone 15. Patients who were referred to the OMM service

Design outcomes

Primary

MeasureTime frameDescription
Time on ventilator90 daysNumber of days that the patient is on the ventilator after inclusion in the study

Secondary

MeasureTime frameDescription
Ventilator associated measurement90 daysVBG/ABG
Blood pressure90 daysBlood pressure
Mental status90 daysWhether awake and oriented x 3
Reintubation90 daysReintubation after extubation
Mortality90 daysDeath

Contacts

Primary ContactLeslie Ching, DO
leslie.ching@okstate.edu540-818-2801
Backup ContactCameron Henderson, DO
cameron.henderson@okstate.edu5804840849

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026